Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1998
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2000 1
2001 1
2002 2
2003 1
2005 2
2007 1
2008 1
2012 1
2013 2
2014 3
2015 3
2016 3
2017 3
2018 6
2019 2
2020 6
2021 14
2022 9
2023 2
2024 5
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Response.
Zasowski EJ, Bassetti M, Blasi F, Rello J, Sotgiu G, Tavoschi L, Arber MR, McCool R, Patterson JV, Longshaw CM, Lopes S, Manissero D, Nguyen ST, Tone K, Aliberti S. Zasowski EJ, et al. Among authors: longshaw cm. Chest. 2021 Apr;159(4):1677-1678. doi: 10.1016/j.chest.2020.11.029. Epub 2021 Apr 6. Chest. 2021. PMID: 34021997 Free article. No abstract available.
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial.
Guery B, Menichetti F, Anttila VJ, Adomakoh N, Aguado JM, Bisnauthsing K, Georgopali A, Goldenberg SD, Karas A, Kazeem G, Longshaw C, Palacios-Fabrega JA, Cornely OA, Vehreschild MJGT; EXTEND Clinical Study Group. Guery B, et al. Among authors: longshaw c. Lancet Infect Dis. 2018 Mar;18(3):296-307. doi: 10.1016/S1473-3099(17)30751-X. Epub 2017 Dec 19. Lancet Infect Dis. 2018. PMID: 29273269 Clinical Trial.
In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations.
Santerre Henriksen A, Jeannot K, Oliver A, Perry JD, Pletz MW, Stefani S, Morrissey I, Longshaw C; ARTEMIS Study Investigators. Santerre Henriksen A, et al. Among authors: longshaw c. Microbiol Spectr. 2024 Apr 2;12(4):e0383623. doi: 10.1128/spectrum.03836-23. Epub 2024 Mar 14. Microbiol Spectr. 2024. PMID: 38483164 Free PMC article.
In vitro activity of cefiderocol against European Enterobacterales, including isolates resistant to meropenem and recentβ-lactam/β-lactamase inhibitor combinations.
Santerre Henriksen A, Arena F, Attwood M, Canton R, Gatermann S, Naas T, Morrissey I, Longshaw C; ARTEMIS Study Investigators. Santerre Henriksen A, et al. Among authors: longshaw c. Microbiol Spectr. 2024 Jun 21;12(8):e0418123. doi: 10.1128/spectrum.04181-23. Online ahead of print. Microbiol Spectr. 2024. PMID: 38904361 Free PMC article.
Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins.
Wagenlehner F, Lucenteforte E, Pea F, Soriano A, Tavoschi L, Steele VR, Henriksen AS, Longshaw C, Manissero D, Pecini R, Pogue JM. Wagenlehner F, et al. Among authors: longshaw c. Clin Microbiol Infect. 2021 Jan 6:S1198-743X(20)30764-3. doi: 10.1016/j.cmi.2020.12.009. Online ahead of print. Clin Microbiol Infect. 2021. PMID: 33359542 Free article. Review.
Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reporting.
Sadouki Z, McHugh TD, Aarnoutse R, Ortiz Canseco J, Darlow C, Hope W, van Ingen J, Longshaw C, Manissero D, Mead A, Pelligand L, Phee L, Readman J, Ruth MM, Standing JF, Stone N, Wey EQ, Kloprogge F. Sadouki Z, et al. Among authors: longshaw c. J Antimicrob Chemother. 2021 Aug 12;76(9):2252-2259. doi: 10.1093/jac/dkab160. J Antimicrob Chemother. 2021. PMID: 34179966 Free PMC article.
62 results